glp 1 agonist in heart failure Glucagon-like peptide receptor agonists: cardiovascular benefits and mechanisms of action The effect of GLP-1 receptor

These challenges are not unique to peptides and increasingly characterize modern therapeutics across oncology, neurology, and immunology

Impact of intentional weight loss in cardiometabolic disease: what we know about timing of benefits on differing outcomes

Nausea, vomiting, and diarrheathe most frequently reported adverse effects of GLP-1 medicationscan lead to dehydration, electrolyte imbalances, and poor nutrient absorption

[DOI] [PMC free article] [PubMed] [Google Scholar] 158.Nauck MA

Front Endocrinol (Lausanne) 2024;15 doi: 10.3389/fendo.2024.1431292

The DPP-4 inhibitor linagliptin and the GLP-1 receptor agonist exendin-4 improve endothelium-dependent relaxation of rat mesenteric arteries in the presence of high glucose